Sign Up Today and Learn More About ConcertAI Stock
Invest in or calculate the value of your shares in ConcertAI or other pre-IPO companies through EquityZen's platform.
ConcertAI Stock (COAI)
ConcertAI is an AI-powered SaaS data company in healthcare that develops medical research tool in oncology.
About ConcertAI Stock
Founded
2018
Headquarters
Boston, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
ConcertAI Press Mentions
Stay in the know about the latest news on ConcertAI
ConcertAI Introduces Cadence Suite, Delivering Industry L...
pharmiweb • Apr 22, 2026
ConcertAI Introduces Cadence Suite, Delivering Industry Leading Visibility and Predictive Insights into the Patient’s Journey for Commercial Teams
businesswire • Apr 21, 2026
Artificial Intelligence (AI) in Precision Medicine Market
prnewswire • Mar 25, 2026
Global Artificial Intelligence (AI) in Precision Medicine Market to Attain USD 10.32 Billion by 2032, Witnessing a CAGR of 31.35%, Says MarkNtel Advisors
prnewswire • Mar 25, 2026
The Pharma Letter Podcast — Episode 37— ConcertAI CEO Eron Kelly on Big Tech's role in biotech
thepharmaletter • Mar 14, 2026
ConcertAI Management
Leadership team at ConcertAI
Director of Software Engineering
Vivek Agarwal
Series B Investor and Board Observer
Ambar Bhattacharyya
Join now and verify your accreditation status to gain access to:
- ConcertAI Current Valuation
- ConcertAI Stock Price
- ConcertAI Management
- Available deals in ConcertAI and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- ConcertAI Cap Table and Funding History by Share Class and Liquidity Preferences
- ConcertAI Revenue and Financials
- ConcertAI Highlights
- ConcertAI Business Model
- ConcertAI Risk Factors
- ConcertAI Research Report from SACRA Research
Trading ConcertAI Stock
How to invest in ConcertAI stock?
Accredited investors can buy pre-IPO stock in companies like ConcertAI through EquityZen funds. These investments are made available by existing ConcertAI shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell ConcertAI stock?
Shareholders can sell their ConcertAI stock through EquityZen's private company marketplace. EquityZen's network includes over 450K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 53K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
